measuregroup/AID184497

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103190517_AID184497_PMID3373496_VALUE4 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103189263_AID184497_PMID3373496_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103190508_AID184497_PMID3373496_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103190538_AID184497_PMID3373496_VALUE5 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103190506_AID184497_PMID3373496_VALUE2
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10116
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title	Antiimplantation activity as minimum effective dose after subcutaneous administration.
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103190538 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103190506 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103190508 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103190517 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103189263
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID184497

Total number of triples: 15.